Electron cryo-microscopy structure of a human TRPM4 channel

Nature

Volumn 552, Issue 7684, 2017, Pages 200-205

  Winkler, Paige A ^a   Huang, Yihe ^a   Sun, Weinan ^b   Du, Juan ^a   Lü, Wei ^a  

^a VAN ANDEL INSTITUTE   (United States)

^b Janelia Research Campus ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL STIMULATING AGENT; DECAVANADATE; GLUTAMINE; TRANSIENT RECEPTOR POTENTIAL CHANNEL M4; UNCLASSIFIED DRUG; CALCIUM; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRPM4 PROTEIN, HUMAN; VANADIC ACID;

ACTIVITY PATTERN; CATION; CONCENTRATION (COMPOSITION); ELECTRON MICROSCOPY; HOMOLOGY; PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CHANNEL GATING; CONTROLLED STUDY; CRYOELECTRON MICROSCOPY; CYTOSOL; HEK293 CELL LINE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR MODEL; ULTRASTRUCTURE;

BINDING SITES; CALCIUM; CRYOELECTRON MICROSCOPY; HUMANS; MODELS, MOLECULAR; PROTEIN DOMAINS; TRPM CATION CHANNELS; VANADATES;

EID: 85038233711     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature24674     Document Type: Article

References (59)

1. 2+-activated cation channel TRPM4. J. Biol. Chem. 278, 30813-30820 (2003).
2. 2+-activated nonselective cation channel mediating cell membrane depolarization. Cell 109, 397-407 (2002).
3. Clémençon, B. et al. Expression, purifcation, and projection structure by single particle electron microscopy of functional human TRPM4 heterologously expressed in Xenopus laevis oocytes. Protein Expr. Purif. 95, 169-176 (2014).
4. Constantine, M. et al. Heterologously-expressed and liposome-reconstituted human transient receptor potential melastatin 4 channel (TRPM4) is a functional tetramer. Sci. Rep. 6, 19352 (2016).
5. Guinamard, R., Demion, M., Magaud, C., Potreau, D. & Bois, P. Functional expression of the TRPM4 cationic current in ventricular cardiomyocytes from spontaneously hypertensive rats. Hypertension 48, 587-594 (2006).
6. Harteneck, C. Function and pharmacology of TRPM cation channels. Naunyn Schmiedebergs Arch. Pharmacol. 371, 307-314 (2005).
7. Kraft, R. & Harteneck, C. The mammalian melastatin-related transient receptor potential cation channels: an overview. Pfugers Arch. 451, 204-211 (2005).
8. Clapham, D. E. TRP channels as cellular sensors. Nature 426, 517-524 (2003).
9. Fleig, A. & Penner, R. The TRPM ion channel subfamily: molecular, biophysical and functional features. Trends Pharmacol. Sci. 25, 633-639 (2004).
10. 2+ permeable cation channels: from gene to biological function. Cell Calcium 33, 519-531 (2003).
11. 2+-activated nonselective cation channel by diacylglycerol analogues in rat cardiomyocytes. J. Cardiovasc. Electrophysiol. 15, 342-348 (2004).
12. Earley, S., Waldron, B. J. & Brayden, J. E. Critical role for transient receptor potential channel TRPM4 in myogenic constriction of cerebral arteries. Circ. Res. 95, 922-929 (2004).
13. Gonzales, A. L., Garcia, Z. I., Amberg, G. C. & Earley, S. Pharmacological inhibition of TRPM4 hyperpolarizes vascular smooth muscle. Am. J. Physiol. Cell Physiol. 299, C1195-C1202 (2010).
14. Barbet, G. et al. The calcium-activated nonselective cation channel TRPM4 is essential for the migration but not the maturation of dendritic cells. Nat. Immunol. 9, 1148-1156 (2008).
15. 2+-activated cation channel gene TRPM4 in patients with cardiac conductance disturbances. Hum. Mutat. 33, 109-117 (2012).
16. Liu, H. et al. Molecular genetics and functional anomalies in a series of 248 Brugada cases with 11 mutations in the TRPM4 channel. PLoS ONE 8, e54131 (2013).
17. Demion, M. et al. Trpm4 gene invalidation leads to cardiac hypertrophy and electrophysiological alterations. PLoS ONE 9, e115256 (2014).
18. Hof, T. et al. TRPM4 non-selective cation channels infuence action potentials in rabbit Purkinje fbres. J. Physiol. (Lond.) 594, 295-306 (2016).
19. 2+-activated cation channels TRPM4 and TRPM5 from mice. Cell Calcium 37, 267-278 (2005).
20. 2+-activated monovalent selective cation channel. Curr. Biol. 13, 1153-1158 (2003).
21. Nilius, B., Prenen, J., Janssens, A., Voets, T. & Droogmans, G. Decavanadate modulates gating of TRPM4 cation channels. J. Physiol. (Lond.) 560, 753-765 (2004).
22. 2+-activated cation channel TRPM4 is regulated by phosphatidylinositol 4, 5-biphosphate. EMBO J. 25, 467-478 (2006).
23. Zhang, Z., Okawa, H., Wang, Y. & Liman, E. R. Phosphatidylinositol 4, 5-bisphosphate rescues TRPM4 channels from desensitization. J. Biol. Chem. 280, 39185-39192 (2005).
24. Liao, M., Cao, E., Julius, D. & Cheng, Y. Structure of the TRPV1 ion channel determined by electron cryo-microscopy. Nature 504, 107-112 (2013).
25. Cao, E., Liao, M., Cheng, Y. & Julius, D. TRPV1 structures in distinct conformations reveal activation mechanisms. Nature 504, 113-118 (2013).
26. Shen, P. S. et al. The structure of the polycystic kidney disease channel PKD2 in lipid nanodiscs. Cell 167, 763-773 (2016).
27. Paulsen, C. E., Armache, J. P., Gao, Y., Cheng, Y. & Julius, D. Structure of the TRPA1 ion channel suggests regulatory mechanisms. Nature 520, 511-517 (2015).
28. Jin, P. et al. Electron cryo-microscopy structure of the mechanotransduction channel NOMPC. Nature 547, 118-122 (2017).
29. Chubanov, V. et al. Disruption of TRPM6/TRPM7 complex formation by a mutation in the TRPM6 gene causes hypomagnesemia with secondary hypocalcemia. Proc. Natl Acad. Sci. USA 101, 2894-2899 (2004).
30. Sun, J. & MacKinnon, R. Cryo-EM structure of a KCNQ1/CaM complex reveals insights into congenital long QT syndrome. Cell 169, 1042-1050 (2017).
31. Launay, P. et al. TRPM4 regulates calcium oscillations after T cell activation. Science 306, 1374-1377 (2004).
32. Fujiwara, Y. & Minor, D. L. Jr. X-ray crystal structure of a TRPM assembly domain reveals an antiparallel four-stranded coiled-coil. J. Mol. Biol. 383, 854-870 (2008).
33. Gregorio-Teruel, L. et al. The integrity of the TRP domain is pivotal for correct TRPV1 channel gating. Biophys. J. 109, 529-541 (2015).
34. García-Sanz, N. et al. A role of the transient receptor potential domain of vanilloid receptor I in channel gating. J. Neurosci. 27, 11641-11650 (2007).
35. Gregorio-Teruel, L., Valente, P., González-Ros, J. M., Fernández-Ballester, G. & Ferrer-Montiel, A. Mutation of I696 and W697 in the TRP box of vanilloid receptor subtype I modulates allosteric channel activation. J. Gen. Physiol. 143, 361-375 (2014).
36. Valente, P. et al. Identifcation of molecular determinants of channel gating in the transient receptor potential box of vanilloid receptor I. FASEB J. 22, 3298-3309 (2008).
37. + channel in a lipid membrane-like environment. Nature 450, 376-382 (2007).
38. Voets, T., Owsianik, G., Janssens, A., Talavera, K. & Nilius, B. TRPM8 voltage sensor mutants reveal a mechanism for integrating thermal and chemical stimuli. Nat. Chem. Biol. 3, 174-182 (2007).
39. Lin, Z. et al. Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome. Am. J. Hum. Genet. 90, 558-564 (2012).
40. Rohács, T., Lopes, C. M., Michailidis, I. & Logothetis, D. E. PI(4, 5)P2 regulates the activation and desensitization of TRPM8 channels through the TRP domain. Nat. Neurosci. 8, 626-634 (2005).
41. Ahuja, S. et al. Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist. Science 350, aac5464 (2015).
42. v1.1 at 3.6 Å resolution. Nature 537, 191-196 (2016).
43. Nilius, B. et al. The selectivity flter of the cation channel TRPM4. J. Biol. Chem. 280, 22899-22906 (2005).
44. García-Martínez, C., Morenilla-Palao, C., Planells-Cases, R., Merino, J. M. & Ferrer-Montiel, A. Identifcation of an aspartic residue in the P-loop of the vanilloid receptor that modulates pore properties. J. Biol. Chem. 275, 32552-32558 (2000).
45. 2+ selectivity of a voltage-gated calcium channel. Nature 505, 56-61 (2014).
46. Goehring, A. et al. Screening and large-scale expression of membrane proteins in mammalian cells for structural studies. Nat. Protoc. 9, 2574-2585 (2014).
47. Varga, S., Csermely, P. & Martonosi, A. The binding of vanadium (V) oligoanions to sarcoplasmic reticulum. Eur. J. Biochem. 148, 119-126 (1985).
48. 2+-and ATP-sensitive cation channels in brain capillaries by nucleotides and decavanadate. J. Gen. Physiol. 123, 743-757 (2004).
49. Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36-51 (2005).
50. Zheng, S., Palovcak, E., Armache, J.-P., Cheng, Y. & Agard, D. Anisotropic correction of beam-induced motion for improved single-particle electron cryo-microscopy. bioRxiv (2016).
51. Zhang, K. Gctf: Real-time CTF determination and correction. J. Struct. Biol. 193, 1-12 (2016).
52. Scheres, S. H. W. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519-530 (2012).
53. Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290-296 (2017).
54. Grigorief, N. Frealign. Methods Enzymol. 579, 191-226 (2016).
55. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486-501 (2010).
56. Singharoy, A. et al. Molecular dynamics-based refnement and validation for sub-5 Å cryo-electron microscopy maps. eLife 5, e16105 (2016).
57. Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D 66, 12-21 (2010).
58. Pettersen, E. F. et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612 (2004).
59. DeLano, W. L. The PyMOL Molecular Graphics System; http://www.pymol.org (2002).